Advanced search
Publication Cover
Cancer Investigation Volume 23, 2005 - Issue 3
Submit an article Journal homepage
43
Views
7
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

A Phase II Study on the Safety and Efficacy of 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) Followed by Paclitaxel in the Adjuvant Treatment of Breast Cancer

Dr. Mustafa Erman Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, TurkeyCorrespondence[email protected]
,
Esmen Baltali Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Aziz Karaoglu Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Huseyin Abali Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Huseyin Engin Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Yavuz Ozisik Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Nilufer Guler Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Kadri Altundag Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
I. Lale Atahan Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Demirali Onat Department of General Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey
,
Iskender Sayek Department of General Surgery, Hacettepe University Faculty of Medicine, Ankara, Turkey
&
Gulten Tekuzman Department of Internal Medicine, Section of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey
 show all
Pages 215-221 | Published online: 11 Jun 2009

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Janos Nadas & Duxin Sun. (2006) Anthracyclines as effective anticancer drugs. Expert Opinion on Drug Discovery 1:6, pages 549-568.
Read now

Articles from other publishers (6)

Yajie Lu, Wei Pan, Shizhou Deng, Qiongyi Dou, Xiangxu Wang, Qiang An, Xiaowen Wang, Hongchen Ji, Yue Hei, Yan Chen, Jingyue Yang & Hong-Mei Zhang. (2023) Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals 16:4, pages 510.
Crossref
Maryam Abdolahi-Majd, Gholamhossein Hassanshahi, Mahboubeh Vatanparast & Mojgan Noroozi Karimabad. (2022) Investigation of the Effect of Prunus Amygdalus Amara on the Expression of some Genes of Apoptosis and Immortality in Breast Cancer Cells (MCF- 7). Current Drug Research Reviews 14:1, pages 73-79.
Crossref
Lisa K. Sprod, City C. Hsieh, Reid Hayward & Carole M. Schneider. (2010) Three versus six months of exercise training in breast cancer survivors. Breast Cancer Research and Treatment 121:2, pages 413-419.
Crossref
Carlos María Galmarini, Benjamin Pierre Bouchet, Carole Audoynaud, Christelle Lamblot, Nicole Falette, Jacques Bertholon, Qing Wang, Anne Beghin, Charles Dumontet & Alain Puisieux. (2006) A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells. International Journal of Cancer 119:1, pages 60-66.
Crossref
Vincenzo Amico, Vincenza Barresi, Daniele Condorelli, Carmela Spatafora & Corrado Tringali. (2006) Antiproliferative Terpenoids from Almond Hulls ( Prunus dulcis ):  Identification and Structure−Activity Relationships . Journal of Agricultural and Food Chemistry 54:3, pages 810-814.
Crossref
. (2005) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 14:12, pages i-xii.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.